Edukasi Monitoring Efek Samping Obat (MESO) pada Pengunjung Car Free Day Kabupaten Lombok Utara
Education on Adverse Drug Reaction Monitoring among Car-Free Day Participants in North Lombok Regency
DOI:
https://doi.org/10.31764/jlp.167Keywords:
Farmakovigilans, Monitoring Efek Samping Obat, Edukasi Kesehatan, Keselamatan Pasien, e-MESOAbstract
Pelaporan dugaan efek samping obat merupakan komponen penting farmakovigilans, tetapi partisipasi masyarakat masih dapat terhambat oleh rendahnya pengetahuan tentang gejala yang perlu dicurigai dan cara melapor. Kegiatan pengabdian ini bertujuan memberikan edukasi Monitoring Efek Samping Obat (MESO) serta memperkenalkan jalur pelaporan yang aman kepada pengunjung Car Free Day Kabupaten Lombok Utara. Kegiatan dilaksanakan pada Minggu, 16 November 2025 mulai pukul 06.00 WITA oleh delapan mahasiswa S1 Farmasi dengan pendampingan dosen. Metode meliputi penyuluhan langsung, penjelasan menggunakan banner dan brosur, pembagian media edukasi, serta tanya jawab. Materi mencakup pengertian efek samping obat, tanda yang perlu diwaspadai, informasi yang perlu dicatat, tindakan awal yang tepat, dan pelaporan melalui tenaga kesehatan, pemilik izin edar, atau aplikasi
e-MESO 2.0 Badan POM. Evaluasi dilakukan secara deskriptif berdasarkan keterlaksanaan kegiatan dan dokumentasi, tanpa pre-test dan post-test. Kegiatan terlaksana sesuai rencana dan menghasilkan media edukasi serta komunikasi langsung dengan masyarakat. Edukasi di ruang publik layak digunakan sebagai langkah awal peningkatan literasi farmakovigilans, tetapi kegiatan berikutnya perlu menambahkan evaluasi kuantitatif, simulasi pelaporan, dan kode QR menuju e-MESO 2.0.
Abstract
Suspected adverse drug reaction reporting is an essential component of pharmacovigilance, yet public participation may be limited by poor knowledge of warning signs and reporting procedures. This community service activity aimed to provide education on adverse drug reaction monitoring and introduce safe reporting pathways to visitors of the Car Free Day event in North Lombok Regency. The activity was conducted on Sunday, 16 November 2025, from 06:00 Central Indonesian Time by eight undergraduate pharmacy students under faculty supervision. The methods included face-to-face counselling, explanations using a banner and brochure, distribution of educational materials, and a question-and-answer session. The content covered the meaning of adverse drug reactions, warning signs, information that should be recorded, appropriate initial actions, and reporting through health professionals, marketing authorization holders, or the Indonesian Food and Drug Authority e-MESO 2.0 platform. Evaluation was descriptive and focused on implementation and documentation; no pre-test or post-test was conducted. The planned activities were completed and produced educational media and direct communication with the public. Public-space education is feasible as an initial approach to improve pharmacovigilance literacy. Future programs should incorporate quantitative evaluation, reporting simulations, and a QR code linked to e-MESO 2.0.
References
Assanee, J., Sorofman, B. A., Sirisinsuk, Y., & Kitisopee, T. (2022). Factors influencing patient intention to report adverse drug reaction to community pharmacists: A structural equation modeling approach. Research in Social and Administrative Pharmacy, 18(4), 2643-2650. https://doi.org/10.1016/j.sapharm.2021.05.010
Badan Pengawas Obat dan Makanan Republik Indonesia. (2026a). Peraturan Badan Pengawas Obat dan Makanan Nomor 4 Tahun 2026 tentang Pelaksanaan Farmakovigilans. Jakarta: Badan POM RI.
Badan Pengawas Obat dan Makanan Republik Indonesia. (2026b). Buku Saku Pelaporan Komoditi Obat bagi Masyarakat melalui Aplikasi e-MESO 2.0. Jakarta: Pusat Farmakovigilans/MESO Nasional, Badan POM RI. https://e-meso.pom.go.id/user-guide/buku-saku
Badan Pengawas Obat dan Makanan Republik Indonesia. (2026c). Panduan Pelaporan Farmakovigilans (Komoditi Obat) bagi Tenaga Medis, Tenaga Kesehatan, dan Pemilik Izin Edar Menggunakan Aplikasi e-MESO 2.0 (Edisi I). Jakarta: Pusat Farmakovigilans/MESO Nasional, Badan POM RI. https://e-meso.pom.go.id/user-guide/panduan-pelaporan
Bagheri, H. (2024). Patient's reporting of adverse drug reactions: Which added value in 2023? Therapie, 79(2), 155-159. https://doi.org/10.1016/j.therap.2023.09.009
Cervantes-Arellano, M. J., Castelán-Martínez, O. D., Marín-Campos, Y., Chávez-Pacheco, J. L., Morales-Ríos, O., et al. (2024). Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic review and meta-analysis. DARU Journal of Pharmaceutical Sciences, 32, 421-434. https://doi.org/10.1007/s40199-024-00508-z
Menang, O., de Soyres-Kuemmerle, A., Maigetter, K., & Burri, C. (2023). Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: A scoping review. BMJ Open, 13, e071079. https://doi.org/10.1136/bmjopen-2022-071079
Paudyal, V., Al-Hamid, A., Bowen, M., Abdul-Hadi, M., Shahzad-Hasan, S., Jalal, Z., & Stewart, D. (2020). Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: Systematic review and meta-analysis. Expert Opinion on Drug Safety, 19(9), 1173-1191. https://doi.org/10.1080/14740338.2020.1807003
Shafei, L., Mekki, L., Maklad, E., Alhathal, T., Ghanem, R., Almalouf, R., Stewart, D., & Nazar, Z. (2023). Factors that influence patient and public adverse drug reaction reporting: A systematic review using the theoretical domains framework. International Journal of Clinical Pharmacy, 45, 801-813. https://doi.org/10.1007/s11096-023-01591-z
World Health Assembly. (2026). Advancing smart, efficient pharmacovigilance as an essential tool for robust, sustainable, resilient and responsive health systems, for everyone, everywhere (WHA79.11). Geneva: World Health Organization.
World Health Organization. (2025). The global smart pharmacovigilance strategy. Geneva: World Health Organization. ISBN 978-92-4-011675-7.
Downloads
Published
How to Cite
License
Copyright (c) 2026 Baiq Nurbaety, Baiq Nurdian, Bastian, Akmah, Alfia Rizki Zuliana, Arifa Sarifatul Husna, Arina Salsabila, Baiq Luthfia Safira, Nurjihad, Yuli Fitriana, Nur Furqani, Taufan Hari Sugara
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in Lumbung Pengabdian Kesehatan (JLP) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright and grant the journal the right of first publication. Users are permitted to read, download, copy, distribute, print, search, or link to the full text of articles, provided that proper acknowledgment is given to the authors and Lumbung Pengabdian Kesehatan (JLP) as the original source of publication.
Artikel yang diterbitkan dalam Lumbung Pengabdian Kesehatan (JLP) dilisensikan di bawah Creative Commons Attribution 4.0 International License (CC BY 4.0). Penulis tetap memegang hak cipta dan memberikan hak publikasi pertama kepada jurnal. Pengguna diperbolehkan membaca, mengunduh, menyalin, mendistribusikan, mencetak, menelusuri, atau menautkan teks lengkap artikel, dengan tetap memberikan pengakuan yang sesuai kepada penulis dan Lumbung Pengabdian Kesehatan (JLP) sebagai sumber publikasi asli.
